Voleon Capital Management’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.71M Buy
+7,496
New +$1.9M 0.03% 368
2026
Q2
– Sell
-67,839
Closed -$15.5M – 776
2026
Q1
$15.5M Sell
67,839
-1,550
-2% -$347K 0.33% 61
2025
Q4
$14.8M Buy
69,389
+37,463
+117% +$7.74M 0.32% 67
2025
Q3
$6.35M Buy
+31,926
New +$5.95M 0.16% 137

Other funds holding ASND

Voleon Capital Management's ASND Position: Q3 2026 in Review

Voleon Capital Management opened a new position in Ascendis Pharma (ASND) in Q3 2026: 7,496 shares worth $1.71M. The stake represents 0.03% of the portfolio and ranks #368 among its holdings. This is a return to the name: Voleon Capital Management previously reported a position in ASND as recently as Q1 2026.

Voleon Capital Management first reported a position in ASND in Q3 2025 and has held it in 4 quarters since. The position peaked at $15.5M in Q1 2026. 347 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • Voleon Capital Management held 7,496 shares of Ascendis Pharma worth $1.71M as of Q3 2026.
  • Ascendis Pharma was a new Voleon Capital Management position in Q3 2026.
  • Ascendis Pharma made up 0.03% of Voleon Capital Management's portfolio in Q3 2026, its #368 holding.
  • Voleon Capital Management first reported a position in Ascendis Pharma in Q3 2025 and has held it in 4 quarters since.
  • Voleon Capital Management's Ascendis Pharma position peaked at $15.5M in Q1 2026.
  • 347 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.

Based on Voleon Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.